Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses

Identifieur interne : 000115 ( Hal/Corpus ); précédent : 000114; suivant : 000116

Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses

Auteurs : Corinne Bergeron

Source :

RBID : Hal:tel-00625467

Descripteurs français

English descriptors

Abstract

The packaging of the eight segments corresponding to the influenza A viruses genomeis a key process of the viral replication as well as a stake of actual scientific researchesbecause it leads to reassortant viruses, e.g. pandemic viruses. We studied the two main facetsof influenza segment packaging: reassortment, during vaccine seeds production and foreignsegment incorporation for influenza vector construction. Vaccine seeds are produced bycoinfection of hens’ eggs with two viruses, a donor one (reference circulating strain) and anacceptor one (A/Puerto Rico/8/34 (H1N1) (PR8)). Analysis of internal genetic composition ofthirteen H3N2 vaccine seeds reveals that PB1 segment of H3N2 donor strain is incorporatedin more than fifty per cent of the cases. Moreover, coinfection events lead to an extremelywide range of reassortants from 6:2 to 2:6 (PR8:H3N2). Segment incorporation competitionassays performed using plasmid-based reverse genetics show that selective packaging of PB1segment is based on genetic environment, i.e. viral origin of HA and NA segments. Thesecond part of my PhD work has been devoted to replicative influenza vector based on H3virus isolated from patients without NA segment at the native stage. None of the gfptransgenic constructions containing reporter gene have been incorporated in viral particles,contrary to literature studies performed using H1N1 laboratory-adapted strains. Even ifmolecular mechanisms controlling influenza A viruses segments incorporation remain stillcomplex, genetic background seems to be an essential element which must be considered withinterest.


Url:

Links to Exploration step

Hal:tel-00625467

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses</title>
<title xml:lang="fr">Composition génétique de semences vaccinales H3N2 et construction d'un virus vecteur : une histoire d'encapsidation de segments chez les virus influenza de type A</title>
<author>
<name sortKey="Bergeron, Corinne" sort="Bergeron, Corinne" uniqKey="Bergeron C" first="Corinne" last="Bergeron">Corinne Bergeron</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-42857" status="OLD">
<idno type="RNSR">200717689B</idno>
<orgName>Virologie et Pathologie Humaine</orgName>
<orgName type="acronym">VirPath</orgName>
<date type="start">2007-01-01</date>
<date type="end">2010-12-31</date>
<desc>
<address>
<addrLine>Faculté de Médecine Lyon RTH Laennec 7 rue Guillaume Paradin 69372 LYON CEDEX 08</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-6818" type="direct"></relation>
<relation active="#struct-194495" type="direct"></relation>
<relation active="#struct-301088" type="indirect"></relation>
<relation active="#struct-303623" type="direct"></relation>
<relation name="FRE3011" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-6818" type="direct">
<org type="institution" xml:id="struct-6818" status="VALID">
<idno type="IdRef">149154992</idno>
<orgName>École normale supérieure - Lyon</orgName>
<orgName type="acronym">ENS Lyon</orgName>
<desc>
<address>
<addrLine>15 parvis René Descartes - BP 7000 - 69342 Lyon Cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ens-lyon.eu/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-194495" type="direct">
<org type="institution" xml:id="struct-194495" status="VALID">
<idno type="IdRef">026402823</idno>
<idno type="ISNI">0000000121686185</idno>
<orgName>Université Claude Bernard Lyon 1</orgName>
<orgName type="acronym">UCBL</orgName>
<desc>
<address>
<addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-lyon1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-301088" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301088" type="indirect">
<org type="regroupinstitution" xml:id="struct-301088" status="VALID">
<orgName>Université de Lyon</orgName>
<desc>
<address>
<addrLine>92 rue Pasteur - CS 30122, 69361 Lyon Cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.universite-lyon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="FRE3011" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-00625467</idno>
<idno type="halId">tel-00625467</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-00625467</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-00625467</idno>
<date when="2009-12-11">2009-12-11</date>
<idno type="wicri:Area/Hal/Corpus">000115</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses</title>
<title xml:lang="fr">Composition génétique de semences vaccinales H3N2 et construction d'un virus vecteur : une histoire d'encapsidation de segments chez les virus influenza de type A</title>
<author>
<name sortKey="Bergeron, Corinne" sort="Bergeron, Corinne" uniqKey="Bergeron C" first="Corinne" last="Bergeron">Corinne Bergeron</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-42857" status="OLD">
<idno type="RNSR">200717689B</idno>
<orgName>Virologie et Pathologie Humaine</orgName>
<orgName type="acronym">VirPath</orgName>
<date type="start">2007-01-01</date>
<date type="end">2010-12-31</date>
<desc>
<address>
<addrLine>Faculté de Médecine Lyon RTH Laennec 7 rue Guillaume Paradin 69372 LYON CEDEX 08</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-6818" type="direct"></relation>
<relation active="#struct-194495" type="direct"></relation>
<relation active="#struct-301088" type="indirect"></relation>
<relation active="#struct-303623" type="direct"></relation>
<relation name="FRE3011" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-6818" type="direct">
<org type="institution" xml:id="struct-6818" status="VALID">
<idno type="IdRef">149154992</idno>
<orgName>École normale supérieure - Lyon</orgName>
<orgName type="acronym">ENS Lyon</orgName>
<desc>
<address>
<addrLine>15 parvis René Descartes - BP 7000 - 69342 Lyon Cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ens-lyon.eu/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-194495" type="direct">
<org type="institution" xml:id="struct-194495" status="VALID">
<idno type="IdRef">026402823</idno>
<idno type="ISNI">0000000121686185</idno>
<orgName>Université Claude Bernard Lyon 1</orgName>
<orgName type="acronym">UCBL</orgName>
<desc>
<address>
<addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-lyon1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-301088" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301088" type="indirect">
<org type="regroupinstitution" xml:id="struct-301088" status="VALID">
<orgName>Université de Lyon</orgName>
<desc>
<address>
<addrLine>92 rue Pasteur - CS 30122, 69361 Lyon Cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.universite-lyon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="FRE3011" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Influenza A virus</term>
<term>Packaging</term>
<term>Vaccine</term>
<term>Viral vector</term>
</keywords>
<keywords scheme="mix" xml:lang="fr">
<term>Empaquetage</term>
<term>Semence vaccinale</term>
<term>Vecteur viral</term>
<term>Virus Influenza de type A</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The packaging of the eight segments corresponding to the influenza A viruses genomeis a key process of the viral replication as well as a stake of actual scientific researchesbecause it leads to reassortant viruses, e.g. pandemic viruses. We studied the two main facetsof influenza segment packaging: reassortment, during vaccine seeds production and foreignsegment incorporation for influenza vector construction. Vaccine seeds are produced bycoinfection of hens’ eggs with two viruses, a donor one (reference circulating strain) and anacceptor one (A/Puerto Rico/8/34 (H1N1) (PR8)). Analysis of internal genetic composition ofthirteen H3N2 vaccine seeds reveals that PB1 segment of H3N2 donor strain is incorporatedin more than fifty per cent of the cases. Moreover, coinfection events lead to an extremelywide range of reassortants from 6:2 to 2:6 (PR8:H3N2). Segment incorporation competitionassays performed using plasmid-based reverse genetics show that selective packaging of PB1segment is based on genetic environment, i.e. viral origin of HA and NA segments. Thesecond part of my PhD work has been devoted to replicative influenza vector based on H3virus isolated from patients without NA segment at the native stage. None of the gfptransgenic constructions containing reporter gene have been incorporated in viral particles,contrary to literature studies performed using H1N1 laboratory-adapted strains. Even ifmolecular mechanisms controlling influenza A viruses segments incorporation remain stillcomplex, genetic background seems to be an essential element which must be considered withinterest.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses</title>
<title xml:lang="fr">Composition génétique de semences vaccinales H3N2 et construction d'un virus vecteur : une histoire d'encapsidation de segments chez les virus influenza de type A</title>
<author role="aut">
<persName>
<forename type="first">Corinne</forename>
<surname>Bergeron</surname>
</persName>
<idno type="halauthorid">644339</idno>
<affiliation ref="#struct-42857"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2011-09-21 16:29:35</date>
<date type="whenModified">2019-11-20 02:33:38</date>
<date type="whenReleased">2011-09-22 10:21:00</date>
<date type="whenProduced">2009-12-11</date>
<date type="whenEndEmbargoed">2011-09-21</date>
<ref type="file" target="https://tel.archives-ouvertes.fr/tel-00625467/document">
<date notBefore="2011-09-21"></date>
</ref>
<ref type="file" subtype="author" n="1" target="https://tel.archives-ouvertes.fr/tel-00625467/file/TH2009_Bergeron_Corinne.pdf">
<date notBefore="2011-09-21"></date>
</ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="131274">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">tel-00625467</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-00625467</idno>
<idno type="halBibtex">bergeron:tel-00625467</idno>
<idno type="halRefHtml">Sciences agricoles. Université Claude Bernard - Lyon I, 2009. Français. ⟨NNT : 2009LYO10332⟩</idno>
<idno type="halRef">Sciences agricoles. Université Claude Bernard - Lyon I, 2009. Français. ⟨NNT : 2009LYO10332⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="STAR">STAR - Dépôt national des thèses électroniques</idno>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="ENS-LYON">École Normale Supérieure de Lyon</idno>
<idno type="stamp" n="UNIV-LYON1">Université Claude Bernard - Lyon I</idno>
<idno type="stamp" n="THESES_LYON1" corresp="UNIV-LYON1">Thèses Université Claude Bernard Lyon 1</idno>
<idno type="stamp" n="UDL">UDL</idno>
<idno type="stamp" n="UNIV-LYON">Université de Lyon</idno>
</seriesStmt>
<notesStmt></notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses</title>
<title xml:lang="fr">Composition génétique de semences vaccinales H3N2 et construction d'un virus vecteur : une histoire d'encapsidation de segments chez les virus influenza de type A</title>
<author role="aut">
<persName>
<forename type="first">Corinne</forename>
<surname>Bergeron</surname>
</persName>
<idno type="halauthorid">644339</idno>
<affiliation ref="#struct-42857"></affiliation>
</author>
</analytic>
<monogr>
<idno type="nnt">2009LYO10332</idno>
<imprint>
<date type="dateDefended">2009-12-11</date>
</imprint>
<authority type="institution">Université Claude Bernard - Lyon I</authority>
<authority type="school">École Doctorale Evolution Ecosystèmes Microbiologie Modélisation</authority>
<authority type="supervisor">Bruno Lina</authority>
<authority type="jury">Patrick Potier [Président]</authority>
<authority type="jury">Patrick Mavingui [Rapporteur]</authority>
<authority type="jury">Jacques Izopet [Rapporteur]</authority>
<authority type="jury">Béatrice Riteau [Rapporteur]</authority>
<authority type="jury">Isabelle Legastelois</authority>
<authority type="jury">Michèle Ottmann</authority>
</monogr>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="fr">French</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">Vaccine</term>
<term xml:lang="en">Viral vector</term>
<term xml:lang="en">Influenza A virus</term>
<term xml:lang="en">Packaging</term>
<term xml:lang="fr">Virus Influenza de type A</term>
<term xml:lang="fr">Empaquetage</term>
<term xml:lang="fr">Semence vaccinale</term>
<term xml:lang="fr">Vecteur viral</term>
</keywords>
<classCode scheme="halDomain" n="sdv.sa">Life Sciences [q-bio]/Agricultural sciences</classCode>
<classCode scheme="halTypology" n="THESE">Theses</classCode>
</textClass>
<abstract xml:lang="en">
<p>The packaging of the eight segments corresponding to the influenza A viruses genomeis a key process of the viral replication as well as a stake of actual scientific researchesbecause it leads to reassortant viruses, e.g. pandemic viruses. We studied the two main facetsof influenza segment packaging: reassortment, during vaccine seeds production and foreignsegment incorporation for influenza vector construction. Vaccine seeds are produced bycoinfection of hens’ eggs with two viruses, a donor one (reference circulating strain) and anacceptor one (A/Puerto Rico/8/34 (H1N1) (PR8)). Analysis of internal genetic composition ofthirteen H3N2 vaccine seeds reveals that PB1 segment of H3N2 donor strain is incorporatedin more than fifty per cent of the cases. Moreover, coinfection events lead to an extremelywide range of reassortants from 6:2 to 2:6 (PR8:H3N2). Segment incorporation competitionassays performed using plasmid-based reverse genetics show that selective packaging of PB1segment is based on genetic environment, i.e. viral origin of HA and NA segments. Thesecond part of my PhD work has been devoted to replicative influenza vector based on H3virus isolated from patients without NA segment at the native stage. None of the gfptransgenic constructions containing reporter gene have been incorporated in viral particles,contrary to literature studies performed using H1N1 laboratory-adapted strains. Even ifmolecular mechanisms controlling influenza A viruses segments incorporation remain stillcomplex, genetic background seems to be an essential element which must be considered withinterest.</p>
</abstract>
<abstract xml:lang="fr">
<p>L’empaquetage des huit segments du génome des virus influenza de type A est une des étapes clef du cycle viral. Il intervient également dans l’apparition de virus réassortants, les virus pandémiques par exemple, ce qui en fait un enjeu fondamental de la recherche actuelle.Nous avons étudié ce mécanisme au cours de deux études, la première portant sur les vaccins antigrippaux (réassortiment), la seconde visant à construire un virus vecteur (incorporation d’un segment hétérologue). Les semences vaccinales sont obtenues par co-infection d’oeufs de poule embryonnés avec deux souches virales une donneuse (souche circulante de référence) et une accepteuse (A/Puerto Rico/8/34 (H1N1) (PR8)). L'analyse de la composition génétique de treize semences vaccinales H3N2 montre que le segment PB1 de la souche donneuse est présent dans plus de 50 % des semences analysées et qu’une grande variété de réassortants,allant de 6:2 à 2:6 (PR8:H3N2), peut résulter de ces coinfections. Des expériences de compétition d'encapsidation de segments à l’aide de la génétique inverse révèlent que l'encapsidation sélective du segment PB1 dépend de son environnement génétique notamment l’origine virale des segments HA et NA. La seconde partie de mon travail de thèse a été consacrée à la construction d’un vecteur réplicatif sur la base d’un virus influenza H3 naturel sans segment NA. Aucune des constructions contenant le transgène gfp n’a été incorporée dans les particules virales, contrairement à ce qui a été décrit dans la littérature. Bien que les mécanismes moléculaires régissant l’incorporation des segments des virus influenza A demeurent très complexes, le fond génétique semble être déterminant pour ce processus.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000115 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000115 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:tel-00625467
   |texte=   Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021